IBIO vs WFC · rev $100.0K vs P/E 15, rev $22.62B
iBio, Inc. Common Stock (IBIO) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported WFC revenue for 2026-06-30 was $22.62B. Net income was $6.41B. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
IBIO currently screens at market cap $13.4M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the IBIO and WFC stock pages for the full models.
Not investment advice.